Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Marie Cleton-Jansen

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
The American Journal of Surgical Pathology|October 13, 2015
Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and ChondroblastomaArjen H G Cleven, Saskia Höcker, Inge Briaire-de Bruijn, et al.
BMC Cancer|October 24, 2012
BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumorsStephane Boeuf, Judith V M G Bovée, Burkhard Lehner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcomaAnne-Marie Cleton-Jansen, Hetty M van Beerendonk, Hans J Baelde, et al.
The Journal of Pathology|February 3, 2005
Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomasLeida B Rozeman, Liesbeth Hameetman, Anne-Marie Cleton-Jansen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 18, 2016
Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtypeMarie Kostine, Arjen Hg Cleven, Noel F C C de Miranda, et al.
The Journal of Molecular Diagnostics : JMD|August 25, 2018
Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation SequencingSuk Wai Lam, Anne-Marie Cleton-Jansen, Arjen H G Cleven, et al.
Breast Cancer Research : BCR|November 11, 2005
Expression analysis of candidate breast tumour suppressor genes on chromosome 16qTom van Wezel, Marcel Lombaerts, Eddy H van Roon, et al.
Genes, Chromosomes & Cancer|August 26, 2010
Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcomaAlexander B Mohseny, Chris Tieken, Pieter A van der Velden, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 27, 2011
Functional characterization of osteosarcoma cell lines provides representative models to study the human diseaseAlexander B Mohseny, Isidro Machado, Yongping Cai, et al.
Plos One|November 16, 2013
Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the Wnt/beta-catenin signaling pathwayKarolin H Nord, Jenny Nilsson, Elsa Arbajian, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
The American Journal of Surgical Pathology|October 13, 2015
Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and ChondroblastomaArjen H G Cleven, Saskia Höcker, Inge Briaire-de Bruijn, et al.
BMC Cancer|October 24, 2012
BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumorsStephane Boeuf, Judith V M G Bovée, Burkhard Lehner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcomaAnne-Marie Cleton-Jansen, Hetty M van Beerendonk, Hans J Baelde, et al.
The Journal of Pathology|February 3, 2005
Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomasLeida B Rozeman, Liesbeth Hameetman, Anne-Marie Cleton-Jansen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 18, 2016
Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtypeMarie Kostine, Arjen Hg Cleven, Noel F C C de Miranda, et al.
The Journal of Molecular Diagnostics : JMD|August 25, 2018
Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation SequencingSuk Wai Lam, Anne-Marie Cleton-Jansen, Arjen H G Cleven, et al.
Breast Cancer Research : BCR|November 11, 2005
Expression analysis of candidate breast tumour suppressor genes on chromosome 16qTom van Wezel, Marcel Lombaerts, Eddy H van Roon, et al.
Genes, Chromosomes & Cancer|August 26, 2010
Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcomaAlexander B Mohseny, Chris Tieken, Pieter A van der Velden, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 27, 2011
Functional characterization of osteosarcoma cell lines provides representative models to study the human diseaseAlexander B Mohseny, Isidro Machado, Yongping Cai, et al.
Plos One|November 16, 2013
Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the Wnt/beta-catenin signaling pathwayKarolin H Nord, Jenny Nilsson, Elsa Arbajian, et al.
Pageof 13